Person · CIK 1780085

Huw M. Nash

No filings in the last two years

Earlier: Stoke Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$12.2M

Noticed on Form 144$1.6M

Bought on Form 4$0

Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Stoke Therapeutics	Employee Stock Option (Right to Buy) exercise $14.17, expires Mar 26, 2034, into Common Stock	Directly	60,000	Mar 27, 2024 · Filing · EDGAR
Stoke Therapeutics	Restricted Stock Units expires Mar 15, 2028, into Common Stock	Directly	40,000	Mar 27, 2024 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2024	$33K	$35K
Q2 2024	$1.6M	$1.5M
Q1 2024	$25K	—
Q1 2022	$88K	Not machine-readable
Q4 2021	$418K	Not machine-readable
Q3 2021	$503K	Not machine-readable
Q2 2021	$23K	Not machine-readable
Q1 2021	$338K	Not machine-readable
Q4 2020	$5.9M	Not machine-readable
Q3 2020	$2M	Not machine-readable
Q2 2020	$57K	Not machine-readable
Q1 2020	$1.3M	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Stoke Therapeutics · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 29, 2023 · 3 notices
Jul 2, 2024	2,500 · ~$35K	Jul 2, 2024	Partly sold Sold 2,467 at $13.10 on Jul 2 · $32K likely match Form 4	Filing · EDGAR
May 20, 2024	50,000 · ~$695K	May 20, 2024	Sold as noticed Sold 50,033 in 2 sales, May 20 to Jul 2 · $770K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Apr 1, 2024	61,329 · ~$828K	Apr 1, 2024	Sold as noticed Sold 61,329 in 2 sales, Apr 1 to Apr 1 · $811K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 43 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Stoke Therapeutics: Sold 4,116 at $6.10 on Mar 19, 2024 · $25K	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 200 at $24.07 on Jan 3, 2022 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,103 at $23.40 on Jan 3, 2022 · $49K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,497 at $22.47 on Jan 3, 2022 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,500 at $25.06 on Dec 1, 2021 · $63K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 3,200 at $23.96 on Dec 1, 2021 · $77K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,900 at $25.00 on Nov 3, 2021 · $48K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,610 at $23.72 on Nov 1, 2021 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,190 at $23.41 on Nov 1, 2021 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,700 at $24.83 on Oct 1, 2021 · $142K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,700 at $26.00 on Sep 1, 2021 · $148K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,700 at $28.87 on Aug 2, 2021 · $165K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,700 at $33.33 on Jul 1, 2021 · $190K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 575 at $39.43 on Jun 1, 2021 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 32 at $57.14 on Jan 6, 2021 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 200 at $60.51 on Jan 4, 2021 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,800 at $59.85 on Jan 4, 2021 · $108K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,200 at $59.02 on Jan 4, 2021 · $130K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,500 at $57.66 on Jan 4, 2021 · $86K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 8,015 at $60.00 on Dec 18, 2020 · $481K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 41,985 at $60.00 on Dec 17, 2020 · $2.5M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 400 at $52.72 on Dec 1, 2020 · $21K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 100 at $51.45 on Dec 1, 2020 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,481 at $50.02 on Dec 1, 2020 · $124K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,719 at $49.19 on Dec 1, 2020 · $134K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 50,000 at $45.00 on Nov 10, 2020 · $2.3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,536 at $37.98 on Nov 2, 2020 · $96K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 3,164 at $36.59 on Nov 2, 2020 · $116K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,300 at $34.86 on Oct 1, 2020 · $80K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 3,400 at $34.33 on Oct 1, 2020 · $117K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 17,201 at $30.00 on Sep 9, 2020 · $516K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 30,718 at $30.00 on Sep 8, 2020 · $922K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 700 at $28.71 on Sep 1, 2020 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,000 at $27.60 on Sep 1, 2020 · $138K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 2,081 at $30.00 on Aug 28, 2020 · $62K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 5,700 at $24.73 on Aug 3, 2020 · $141K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,900 at $25.06 on Jul 16, 2020 · $48K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 913 at $22.41 on Jul 7, 2020 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 3,800 at $23.15 on Jul 1, 2020 · $88K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 500 at $27.48 on Jun 1, 2020 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 1,607 at $27.08 on Jun 1, 2020 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 15,995 at $26.37 on Mar 2, 2020 · $422K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics: Sold 33,148 at $25.66 on Mar 2, 2020 · $851K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Stoke Therapeutics Chief Business Officer · filings 2019 to 2024 · sold $12.2M · $1.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 2, 2024	Sale under a 10b5-1 plan	−2,467	$13.10	$32K	33 direct	Filing · EDGAR
Jul 2, 2024	Sale under a 10b5-1 plan	−33	$13.90	$459	0 direct	Filing · EDGAR
May 20, 2024	Option or RSU exercised or converted	+50,000	$0.40	$20K	50,000 direct	Filing · EDGAR
May 20, 2024	Sale under a 10b5-1 plan	−50,000	$15.39	$770K	0 direct	Filing · EDGAR
May 20, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−50,000			46,000 direct	Filing · EDGAR
Apr 1, 2024	Option or RSU exercised or converted	+50,000	$0.40	$20K	61,329 direct	Filing · EDGAR
Apr 1, 2024	Sale under a 10b5-1 plan	−60,929	$13.22	$806K	400 direct	Filing · EDGAR
Apr 1, 2024	Sale under a 10b5-1 plan	−400	$13.61	$5K	0 direct	Filing · EDGAR
Apr 1, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−50,000			96,000 direct	Filing · EDGAR
Mar 27, 2024	Grant or award from the company Employee Stock Option (Right to Buy)	+60,000			60,000 direct	Filing · EDGAR
Mar 27, 2024	Grant or award from the company Restricted Stock Units	+40,000			40,000 direct	Filing · EDGAR
Mar 19, 2024	Open-market or private sale	−4,116	$6.10	$25K	11,329 direct	Filing · EDGAR
Mar 15, 2024	Option or RSU exercised or converted	+13,100			15,445 direct	Filing · EDGAR
Mar 15, 2024	Option or RSU exercised or converted Restricted Stock Units	−13,100			39,300 direct	Filing · EDGAR
Dec 1, 2023	Returned to the company Employee Stock Option (Right to Buy)	−65,600			0 direct	Filing · EDGAR
Dec 1, 2023	Grant or award from the company Restricted Stock Unit (RSU)	+8,463			8,463 direct	Filing · EDGAR
Mar 15, 2023	Grant or award from the company Employee Stock Option (Right to Buy)	+78,600			78,600 direct	Filing · EDGAR
Mar 15, 2023	Grant or award from the company Restricted Stock Unit (RSU)	+52,400			52,400 direct	Filing · EDGAR
Dec 7, 2022	Grant or award from the company Employee Stock Option (Right to Buy)	+62,000			62,000 direct	Filing · EDGAR
Mar 15, 2022	Grant or award from the company Employee Stock Option (Right to Buy)	+107,400			107,400 direct	Filing · EDGAR
Jan 3, 2022	Option or RSU exercised or converted	+3,800	$2.19	$8K	3,800 direct	Filing · EDGAR
Jan 3, 2022	Sale under a 10b5-1 plan	−1,497	$22.47	$34K	2,303 direct	Filing · EDGAR
Jan 3, 2022	Sale under a 10b5-1 plan	−2,103	$23.40	$49K	200 direct	Filing · EDGAR
Jan 3, 2022	Sale under a 10b5-1 plan	−200	$24.07	$5K	0 direct	Filing · EDGAR
Jan 3, 2022	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−3,800			86,822 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,700 direct	Filing · EDGAR
Dec 1, 2021	Sale under a 10b5-1 plan	−3,200	$23.96	$77K	2,500 direct	Filing · EDGAR
Dec 1, 2021	Sale under a 10b5-1 plan	−2,500	$25.06	$63K	0 direct	Filing · EDGAR
Dec 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			90,622 direct	Filing · EDGAR
Nov 3, 2021	Option or RSU exercised or converted	+1,900	$2.19	$4K	1,900 direct	Filing · EDGAR
Nov 3, 2021	Sale under a 10b5-1 plan	−1,900	$25.00	$48K	0 direct	Filing · EDGAR
Nov 3, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−1,900			96,322 direct	Filing · EDGAR
Nov 1, 2021	Option or RSU exercised or converted	+3,800	$2.19	$8K	3,800 direct	Filing · EDGAR
Nov 1, 2021	Sale under a 10b5-1 plan	−2,190	$23.41	$51K	1,610 direct	Filing · EDGAR
Nov 1, 2021	Sale under a 10b5-1 plan	−1,610	$23.72	$38K	0 direct	Filing · EDGAR
Nov 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−3,800			98,222 direct	Filing · EDGAR
Oct 1, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,700 direct	Filing · EDGAR
Oct 1, 2021	Sale under a 10b5-1 plan	−5,700	$24.83	$142K	0 direct	Filing · EDGAR
Oct 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			102,022 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,700 direct	Filing · EDGAR
Sep 1, 2021	Sale under a 10b5-1 plan	−5,700	$26.00	$148K	0 direct	Filing · EDGAR
Sep 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			107,722 direct	Filing · EDGAR
Aug 2, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,700 direct	Filing · EDGAR
Aug 2, 2021	Sale under a 10b5-1 plan	−5,700	$28.87	$165K	0 direct	Filing · EDGAR
Aug 2, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			113,422 direct	Filing · EDGAR
Jul 1, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,700 direct	Filing · EDGAR
Jul 1, 2021	Sale under a 10b5-1 plan	−5,700	$33.33	$190K	0 direct	Filing · EDGAR
Jul 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			119,122 direct	Filing · EDGAR
Jun 1, 2021	Option or RSU exercised or converted	+575	$2.19	$1K	575 direct	Filing · EDGAR
Jun 1, 2021	Sale under a 10b5-1 plan	−575	$39.43	$23K	0 direct	Filing · EDGAR
Jun 1, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−575			124,822 direct	Filing · EDGAR
Mar 2, 2021	Grant or award from the company Employee Stock Option (Right to Buy)	+65,600			65,600 direct	Filing · EDGAR
Jan 6, 2021	Sale under a 10b5-1 plan	−32	$57.14	$2K	0 direct	Filing · EDGAR
Jan 4, 2021	Option or RSU exercised or converted	+5,700	$2.19	$12K	5,732 direct	Filing · EDGAR
Jan 4, 2021	Sale under a 10b5-1 plan	−1,500	$57.66	$86K	4,232 direct	Filing · EDGAR
Jan 4, 2021	Sale under a 10b5-1 plan	−2,200	$59.02	$130K	2,032 direct	Filing · EDGAR
Jan 4, 2021	Sale under a 10b5-1 plan	−1,800	$59.85	$108K	232 direct	Filing · EDGAR
Jan 4, 2021	Sale under a 10b5-1 plan	−200	$60.51	$12K	32 direct	Filing · EDGAR
Jan 4, 2021	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−5,700			125,397 direct	Filing · EDGAR
Dec 18, 2020	Option or RSU exercised or converted	+8,015	$0.60	$5K	8,015 direct	Filing · EDGAR

58 earlier transactions are in the filing list below.

All 38 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Jul 3, 2024	Form 4	Stoke Therapeutics	Filing · EDGAR
Jul 2, 2024	Form 144	Stoke Therapeutics	Filing · EDGAR
Jun 7, 2024	Form 4	Stoke Therapeutics	Filing · EDGAR
May 22, 2024	Form 4	Stoke Therapeutics	Filing · EDGAR
May 20, 2024	Form 144	Stoke Therapeutics	Filing · EDGAR
Apr 3, 2024	Form 4	Stoke Therapeutics	Filing · EDGAR
Apr 1, 2024	Form 144	Stoke Therapeutics	Filing · EDGAR
Mar 19, 2024	Form 4	Stoke Therapeutics	Filing · EDGAR
Dec 5, 2023	Form 4	Stoke Therapeutics	Filing · EDGAR
Mar 17, 2023	Form 4	Stoke Therapeutics	Filing · EDGAR
Dec 9, 2022	Form 4	Stoke Therapeutics	Filing · EDGAR
Mar 17, 2022	Form 4	Stoke Therapeutics	Filing · EDGAR
Jan 5, 2022	Form 4	Stoke Therapeutics	Filing · EDGAR
Dec 3, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Nov 3, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Oct 4, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Sep 2, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Aug 4, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Jul 2, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Jun 3, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Mar 4, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Jan 6, 2021	Form 4	Stoke Therapeutics	Filing · EDGAR
Dec 18, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Dec 3, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Nov 10, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Nov 4, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Oct 5, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Sep 10, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Sep 3, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Aug 31, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Aug 4, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Jul 17, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Jul 9, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Jul 2, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Jun 3, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Mar 26, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Mar 4, 2020	Form 4	Stoke Therapeutics	Filing · EDGAR
Jun 18, 2019	Form 3	Stoke Therapeutics	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 4:30 PM ET. The filing on SEC.gov is the record.